Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.

Trifan A, Girleanu I, Cojocariu C, Sfarti C, Singeap AM, Dorobat C, Grigore L, Stanciu C.

World J Gastroenterol. 2013 Nov 14;19(42):7476-9. doi: 10.3748/wjg.v19.i42.7476.

2.

[Pseudomembranous colitis after Helicobacter pylori eradication therapy].

Kubo N, Kochi S, Ariyama I, Murata M, Furusyo N, Hayashi J.

Kansenshogaku Zasshi. 2006 Jan;80(1):51-5. Japanese.

PMID:
16519125
3.

Pseudomembranous colitis after eradication of Helicobacter pylori infection with a triple therapy.

Harsch IA, Hahn EG, Konturek PC.

Med Sci Monit. 2001 Jul-Aug;7(4):751-4.

PMID:
11433206
4.

Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.

Lee HJ, Kim JI, Lee JS, Jun EJ, Oh JH, Cheung DY, Chung WC, Kim BW, Kim SS.

World J Gastroenterol. 2015 Jan 7;21(1):351-9. doi: 10.3748/wjg.v21.i1.351.

5.

Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.

Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N.

Clin Ther. 2008 Mar;30(3):528-34. doi: 10.1016/j.clinthera.2008.03.009.

PMID:
18405790
6.
7.

Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.

Kim SY, Lee SW, Jung SW, Koo JS, Yim HJ, Park JJ, Chun HJ, Lee HS, Choi JH, Kim CD, Ryu HS.

Helicobacter. 2008 Aug;13(4):282-7. doi: 10.1111/j.1523-5378.2008.00615.x.

PMID:
18665938
8.

Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.

Lim JH, Lee DH, Choi C, Lee ST, Kim N, Jeong SH, Kim JW, Hwang JH, Park YS, Lee SH, Shin CM, Jo HJ, Jang ES, Song Is, Jung HC.

Helicobacter. 2013 Jun;18(3):180-6. doi: 10.1111/hel.12034. Epub 2013 Jan 11.

PMID:
23305083
10.

Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.

Sontag SJ, O'Connell S, Schnell T, Chejfec G, Seidel J, Sonnenberg A.

Am J Gastroenterol. 2001 May;96(5):1390-5.

PMID:
11374672
11.

Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.

Bochenek WJ, Peters S, Fraga PD, Wang W, Mack ME, Osato MS, El-Zimaity HM, Davis KD, Graham DY; Helicobacter pylori Pantoprazole Eradication (HELPPE) Study Group..

Helicobacter. 2003 Dec;8(6):626-42. Erratum in: Helicobacter. 2004 Apr;9(2):183.

PMID:
14632678
12.

Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin.

Oh JH, Dong MS, Choi MG, Yoo HW, Lee SB, Park YI, Chung IS.

J Gastroenterol Hepatol. 2009 Feb;24(2):294-8. doi: 10.1111/j.1440-1746.2008.05605.x. Epub 2008 Sep 24.

PMID:
18823430
13.

Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori.

Sezikli M, Çetinkaya ZA, Güzelbulut F, Yeşil A, Coşgun S, Kurdaş OÖ.

J Clin Pharm Ther. 2012 Jun;37(3):282-5. doi: 10.1111/j.1365-2710.2011.01286.x. Epub 2011 Jul 11.

PMID:
21740452
14.
15.

A case of severe pseudomembranous colitis diagnosed by colonoscopy after Helicobacter pylori eradication.

Sato S, Chinda D, Yamai K, Satake R, Soma Y, Shimoyama T, Fukuda S.

Clin J Gastroenterol. 2014 Jun;7(3):247-50. doi: 10.1007/s12328-014-0490-6. Epub 2014 May 8.

PMID:
26183745
16.

The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.

Sheu BS, Huang JJ, Yang HB, Huang AH, Wu JJ.

Aliment Pharmacol Ther. 2003 May 15;17(10):1283-90.

17.
18.

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.

Greenberg ER, Anderson GL, Morgan DR, Torres J, Chey WD, Bravo LE, Dominguez RL, Ferreccio C, Herrero R, Lazcano-Ponce EC, Meza-Montenegro MM, Peña R, Peña EM, Salazar-Martínez E, Correa P, Martínez ME, Valdivieso M, Goodman GE, Crowley JJ, Baker LH.

Lancet. 2011 Aug 6;378(9790):507-14. doi: 10.1016/S0140-6736(11)60825-8. Epub 2011 Jul 21.

20.

High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin.

Furuta T, Shirai N, Xiao F, Takashita M, Sugimoto M, Kajimura M, Ohashi K, Ishizaki T.

Hepatogastroenterology. 2003 Nov-Dec;50(54):2274-8.

PMID:
14696516

Supplemental Content

Support Center